Clinical Trials Directory

Trials / Completed

CompletedNCT01962077

Comparison of MedCem MTA and Formocresol Used in Pulpotomies in Primary Teeth.

Comparison of MedCem MTA and Formocresol Used in Pulpotomies in Primary Teeth

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Hadassah Medical Organization · Academic / Other
Sex
All
Age
2 Years – 10 Years
Healthy volunteers
Accepted

Summary

assess the effect of MedCem MTA as a pulp medicament following pulpotomy in human primary molars with carious pulp exposure in comparison to Formocresol.

Conditions

Interventions

TypeNameDescription
PROCEDUREMedCem MTA pulpotomies in primary teeth.

Timeline

Start date
2013-10-01
Primary completion
2021-06-01
Completion
2021-06-01
First posted
2013-10-14
Last updated
2021-07-06

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01962077. Inclusion in this directory is not an endorsement.

Comparison of MedCem MTA and Formocresol Used in Pulpotomies in Primary Teeth. (NCT01962077) · Clinical Trials Directory